Side-by-side comparison of AI visibility scores, market position, and capabilities
Payment technology company with $9.2B FY2024 revenue; Issuer Solutions spin-off announced 2024; software-led merchant verticals (Heartland, AdvancedMD); competes with Fiserv, Stripe, Adyen.
Global Payments Inc. is a worldwide provider of payment technology and software solutions, founded in 2001 and headquartered in Atlanta, Georgia, trading on NYSE (GPN). The company generated approximately $9.2 billion in revenues for FY2024 under CEO Cameron Bready, who replaced founder-era CEO Jeff Sloan in 2023. Formed through the 2019 merger with TSYS (Total System Services) in a $21.5 billion deal that doubled the company's scale, Global Payments processes approximately $10 trillion in payments annually across merchant acquiring, issuer processing, and business software verticals. In 2024, the company announced a strategic restructuring: separating its Issuer Solutions business (formerly TSYS card issuer processing) into an independent company and divesting its Gaming solutions segment, sharpening focus on its merchant acquiring and commerce enablement core.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.